Advances in the Diagnosis, Classification, Risk Stratification, and Management of Monoclonal Gammopathy of Undetermined Significance: Implications for Recategorizing Disease Entities in the Presence of Evolving Scientific Evidence. - Mayo Clinic News Network

Advances in the Diagnosis, Classification, Risk Stratification, and Management of Monoclonal Gammopathy of Undetermined Significance: Implications for Recategorizing Disease Entities in the Presence of Evolving Scientific Evidence.

By
Adam Brase

October 4, 2010

Dr. S. Vincent Rajkumar, from the Division of Hematology at Mayo Clinic, discusses advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance and implications for recategorizing disease entities, which will be published in the October 2010 issue of Mayo Clinic Proceedings.
http://www.youtube.com/watch?v=uA6ngreLmVg

Study Shows Simple Finger Device May Help Predict Future Heart Events, Such as Heart Attack

TBI or Traumatic Brain Injury

Cancer

An army of support

Mayo Clinic Minute

Mayo Clinic Minute: The right way to talk with someone who has cancer

Cancer

Treating advanced prostate cancer